LGALS9 and cancer: Ligand receptor analysis revealed that APOE+ macrophages may interact with cancer cells via the SPP1‐CD44 and FN1‐SDC4/CD44 signaling pathways, whereas monocytes and DCs may interact with cancer cells via the LGALS9‐CD44 signaling pathway (Figure S3F, Supporting Information).